ELF5 and breast carcinoma: Higher ELF5 expression in luminal A, but not B breast cancers, was broadly associated with the same five functional networks identified in the PyMT/Elf5 model: HGF and IL4, invasive phenotype, monocytes, immune system involvement, inflammation and the interferon response (S4C and S4D Fig).